{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T10:42:54Z","timestamp":1792233774432,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.eimce.2026.503295","type":"journal-article","created":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:56:15Z","timestamp":1792230975000},"page":"503295","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Characterization of herpes zoster cases and epidemiological trends in the Community of Madrid before and after the vaccine introduction in older adults: 2016\u20132025"],"prefix":"10.1016","author":[{"given":"Laura","family":"Reques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Mar\u00eda","family":"Humanes-Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"C\u00f3rdoba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Jim\u00e9nez-Bueno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Garc\u00eda-Comas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimce.2026.503295_bib0005","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/WNL.0b013e3182a3516e","article-title":"The global epidemiology of herpes zoster","volume":"81","author":"Yawn","year":"2013","journal-title":"Neurology"},{"key":"10.1016\/j.eimce.2026.503295_bib0010","article-title":"Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review","volume":"10","author":"Pan","year":"2022","journal-title":"Ther Adv Vaccines Immunother"},{"key":"10.1016\/j.eimce.2026.503295_bib0015","unstructured":"Centro Nacional de Epidemiolog\u00eda. Vigilancia epidemiol\u00f3gica del Herpes Z\u00f3ster en Espa\u00f1a, 2014-2022. Available from: https:\/\/cne.isciii.es\/documents\/d\/cne\/informe_hz_espana_2014-2022_vfinal."},{"key":"10.1016\/j.eimce.2026.503295_bib0020","series-title":"Recomendaciones de vacunaci\u00f3n frente a Herpes Zoster. Ponencia de Programa y Registro de Vacunaciones 2020. Revisado 2023","author":"Consejo Interterritorial del Sistema Nacional de Salud","year":"2023"},{"key":"10.1016\/j.eimce.2026.503295_bib0025","series-title":"Indicaciones de vacunaci\u00f3n frente al Herpes Zoster","author":"Direcci\u00f3n General de Salud P\u00fablica","year":"2025"},{"key":"10.1016\/j.eimce.2026.503295_bib0030","series-title":"Calendario Com\u00fan de Vacunaci\u00f3n a lo largo toda la vida. A\u00f1o 2026","author":"Consejer\u00eda de Sanidad de la Comunidad de Madrid","year":"2026"},{"key":"10.1016\/j.eimce.2026.503295_bib0035","article-title":"Resultados de la vigilancia de la Red Centinela de la Comunidad de Madrid, a\u00f1o 2017","volume":"24","author":"Direcci\u00f3n General de Salud P\u00fablica","year":"2018","journal-title":"Bol Epidemiol Comun Madrid"},{"key":"10.1016\/j.eimce.2026.503295_bib0040","series-title":"Protocolos de la Red Nacional de Vigilancia Epidemiol\u00f3gica","author":"Instituto de Salud Carlos III","year":"2014"},{"key":"10.1016\/j.eimce.2026.503295_bib0045","unstructured":"World Organization of Family Doctors. International Classification of Primary Care. Second Edition (ICPC-2). Available from: https:\/\/www.helsedirektoratet.no\/digitalisering-og-e-helse\/helsefaglige-kodeverk\/icpc\/icpc-2e--english-version."},{"key":"10.1016\/j.eimce.2026.503295_bib0050","series-title":"Estad\u00edstica Continua de poblaci\u00f3n. Metodolog\u00eda [Internet]","author":"Instituto Nacional de Estad\u00edstica","year":"2026"},{"key":"10.1016\/j.eimce.2026.503295_bib0055","series-title":"Manual de Codificaci\u00f3n CIE-10-ES Diagn\u00f3sticos. Informaci\u00f3n y Estad\u00edsticas sanitarias","author":"Ministerio de Sanidad","year":"2024"},{"key":"10.1016\/j.eimce.2026.503295_bib0060","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2023.28.8.2200390","article-title":"Epidemiology of herpes zoster in the pre-vaccination era: establishing the baseline for vaccination programme's impact in Spain","volume":"28","author":"Risco Risco","year":"2023","journal-title":"Euro Surveill"},{"key":"10.1016\/j.eimce.2026.503295_bib0065","article-title":"Surveillance and epidemiology of Herpes Zoster in Spain","volume":"95","author":"Masa-Calles","year":"2021","journal-title":"Rev Esp Salud Publica"},{"key":"10.1016\/j.eimce.2026.503295_bib0070","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2334-13-170","article-title":"Similar herpes zoster incidence across Europe: results from a systematic literature review","volume":"13","author":"Pinchinat","year":"2013","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.eimce.2026.503295_bib0075","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-004833","article-title":"Systematic review of incidence and complications of herpes zoster: towards a global perspective","volume":"4","author":"Kawai","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/j.eimce.2026.503295_bib0080","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/aje\/kwr206","article-title":"Comparing shingles incidence and complication rates from medical record review and administrative database estimates: how close are they?","volume":"174","author":"Yawn","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.eimce.2026.503295_bib0085","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40121-022-00717-6","article-title":"Hospitalization burden related to herpes zoster infection in Spain (2016\u20132019)","volume":"12","author":"Corcuera-Munguia","year":"2023","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.eimce.2026.503295_bib0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jinf.2015.01.015","article-title":"Temporal trends in herpes zoster-related hospitalizations in Madrid (Spain), 2003\u20132013","volume":"71","author":"Esteban-Vasallo","year":"2015","journal-title":"J Infect"},{"key":"10.1016\/j.eimce.2026.503295_bib0095","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.4161\/hv.28620","article-title":"Sociodemographic characteristics and chronic medical conditions as risk factors for herpes zoster: a population-based study from primary care in Madrid (Spain)","volume":"10","author":"Esteban-Vasallo","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eimce.2026.503295_bib0100","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.mayocp.2012.05.021","article-title":"Chronic medical conditions as risk factors for herpes zoster","volume":"87","author":"Joesoef","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.eimce.2026.503295_bib0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107983","article-title":"Diabetes as a risk factor for herpes zoster in adults: a synthetic literature review","volume":"159","author":"Saadatian-Elahi","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.eimce.2026.503295_bib0110","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s15010-011-0162-0","article-title":"Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study","volume":"39","author":"Hata","year":"2011","journal-title":"Infection"},{"key":"10.1016\/j.eimce.2026.503295_bib0115","series-title":"Indicadores clave del Sistema Nacional de Salud [Internet]","author":"Ministerio de Sanidad, Asuntos Sociales e Igualdad","year":"2024"},{"key":"10.1016\/j.eimce.2026.503295_bib0120","series-title":"Trends in Life Expectancy in EU and Other OECD Countries [Internet]","year":"2019"},{"key":"10.1016\/j.eimce.2026.503295_bib0125","article-title":"The impact of demographic changes on the epidemiology of herpes zoster: Spain as a case study","volume":"282","author":"Marziano","year":"2015","journal-title":"Proc Biol Sci"},{"issue":"suppl_2","key":"10.1016\/j.eimce.2026.503295_bib0130","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1093\/infdis\/jiy418","article-title":"Point-counterpoint: the Hope\u2013Simpson hypothesis and its implications regarding an effect of routine varicella vaccination on Herpes Zoster incidence","volume":"218","author":"Harpaz","year":"2018","journal-title":"J Infect Dis"},{"key":"10.1016\/j.eimce.2026.503295_bib0135","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1016\/j.vaccine.2018.02.021","article-title":"Effectiveness of herpes zoster vaccination in an older United Kingdom population","volume":"36","author":"Walker","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.eimce.2026.503295_bib0140","doi-asserted-by":"crossref","first-page":"e82","DOI":"10.1016\/S2468-2667(17)30234-7","article-title":"Evaluation of the effect of the herpes zoster vaccination programme 3 years after its introduction in England: a population-based study","volume":"3","author":"Amirthalingam","year":"2018","journal-title":"Lancet Public Health"},{"key":"10.1016\/j.eimce.2026.503295_bib0145","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2023.2168952","article-title":"Cost-effectiveness of the recombinant zoster vaccine (RZV) against herpes zoster: an updated critical review","volume":"19","author":"Giannelos","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eimce.2026.503295_bib0150","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/cid\/ciab125","article-title":"Recombinant Zoster vaccine (Shingrix): real-world effectiveness in the first 2 years post-licensure","volume":"73","author":"Izurieta","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.eimce.2026.503295_bib0155","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2366353","article-title":"The public health impact of recombinant herpes zoster vaccination in adults over 50 years in Spain","volume":"20","author":"Garc\u00eda","year":"2024","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.eimce.2026.503295_bib0160","series-title":"Informe de seguimiento de la vacunaci\u00f3n frente a Herpes Z\u00f3ster en la Comunidad de Madrid","author":"Direcci\u00f3n General de Salud P\u00fablica","year":"2025"}],"container-title":["Enfermedades infecciosas y microbiologia clinica (English ed.)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26001796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2529993X26001796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:56:19Z","timestamp":1792230979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2529993X26001796"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":32,"alternative-id":["S2529993X26001796"],"URL":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503295","relation":{},"ISSN":["2529-993X"],"issn-type":[{"value":"2529-993X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of herpes zoster cases and epidemiological trends in the Community of Madrid before and after the vaccine introduction in older adults: 2016\u20132025","name":"articletitle","label":"Article Title"},{"value":"Enfermedades infecciosas y microbiologia clinica (English ed.)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimce.2026.503295","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"503295"}}